Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/23/2000 | WO2000070061A2 Senescence-related promoters |
11/23/2000 | WO2000070060A1 Production of complex carbohydrates |
11/23/2000 | WO2000070059A2 Signal transduction genes and methods of use |
11/23/2000 | WO2000070058A2 Plant cellulose synthase genes |
11/23/2000 | WO2000070057A2 Mutant 1,3-propanediol dehydrogenase |
11/23/2000 | WO2000070056A1 Chloramphenicol biosynthetic pathway and gene cluster characterization |
11/23/2000 | WO2000070055A1 Rnp originating in paramyxovirus |
11/23/2000 | WO2000070054A1 Pathogen-resistant grape plants |
11/23/2000 | WO2000070053A1 Transgenic plants exhibiting an altered flowering time |
11/23/2000 | WO2000070052A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme |
11/23/2000 | WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY |
11/23/2000 | WO2000070050A1 Compositions and methods for the treatment of immune related diseases |
11/23/2000 | WO2000070049A2 Extracellular signaling molecules |
11/23/2000 | WO2000070048A1 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING MURINE ORGANIC ANION TRANSPORTER 6 (mOATP6) AND SCREENING METHODS THEREOF |
11/23/2000 | WO2000070047A2 Full-length molecules expressed in human tissues |
11/23/2000 | WO2000070046A2 Secreted polypeptides and corresponding polynucleotides |
11/23/2000 | WO2000070045A1 Ox2 receptor homologs |
11/23/2000 | WO2000070044A2 Human brain t calcium channel alpha-subunit splice variants |
11/23/2000 | WO2000070043A1 Recombinant human mannan-binding lectin |
11/23/2000 | WO2000070042A1 143 human secreted proteins |
11/23/2000 | WO2000070041A1 Mixed-bed solid phase and its use in the isolation of nucleic acids |
11/23/2000 | WO2000070040A1 Cell concentration and lysate clearance using paramagnetic particles |
11/23/2000 | WO2000070039A1 METHOD FOR SUBTRACTING cDNAs BY SUPPRESSING THE SYNTHESIS OF SPECIFICALLY TARGETED mRNAs |
11/23/2000 | WO2000070038A1 Plasmids and methods for construction of non-redundant, saturation, gene-disruption plant libraries |
11/23/2000 | WO2000070037A2 Directed evolution of microorganisms |
11/23/2000 | WO2000070036A2 Genes expressed in hippocampus |
11/23/2000 | WO2000070032A1 Zace2: a human metalloenzyme |
11/23/2000 | WO2000070028A1 Sphingosine kinase enzyme |
11/23/2000 | WO2000070027A1 Materials and methods for enzymatic n-acetylation of arylalkylamines |
11/23/2000 | WO2000070023A1 Novel fab fragment libraries and methods for their use |
11/23/2000 | WO2000070021A2 Differentiated human embryoid cells and a method for producing them |
11/23/2000 | WO2000070019A2 Process of rapid variety-independent plant transformation |
11/23/2000 | WO2000070017A2 Methods using of fab i and compounds modulating fab i activity |
11/23/2000 | WO2000070016A2 Genetically modified plants tolerant of stress conditions |
11/23/2000 | WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
11/23/2000 | WO2000069912A1 Gene encoding a sodium channel beta-3 subunit protein |
11/23/2000 | WO2000069910A1 Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity |
11/23/2000 | WO2000069907A1 Protein scaffold and its use to multimerise monomeric polypeptides |
11/23/2000 | WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
11/23/2000 | WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
11/23/2000 | WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
11/23/2000 | WO2000069901A2 Proteins with insulin-like activity useful in the treatment of diabetes |
11/23/2000 | WO2000069899A1 Compositions of solvents and high concentrations of nucleic acid analogs |
11/23/2000 | WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
11/23/2000 | WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
11/23/2000 | WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
11/23/2000 | WO2000069888A1 Self-assembling biomolecular structures |
11/23/2000 | WO2000069885A2 Secreted proteins and uses thereof |
11/23/2000 | WO2000069884A2 Compositions isolated from skin cells and methods for their use |
11/23/2000 | WO2000069883A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
11/23/2000 | WO2000069872A2 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS |
11/23/2000 | WO2000069462A1 Human monoclonal antibody |
11/23/2000 | WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
11/23/2000 | WO2000069454A1 Suppression of endogenous igfbp-2 to inhibit cancer |
11/23/2000 | WO2000069268A1 Production of human cells, tissues, and organs in animals |
11/23/2000 | WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
11/23/2000 | WO2000050609B1 MAIZE ADENOSINE DEAMINASE cDNA AND USES THEREOF |
11/23/2000 | WO2000046375A3 Methods for producing polypeptides in fungal cells |
11/23/2000 | WO2000046245A3 Human antibiotic proteins |
11/23/2000 | WO2000043410A3 Novel odorant receptors in drosophila |
11/23/2000 | WO2000042560A3 Methods for making character strings, polynucleotides and polypeptides |
11/23/2000 | WO2000041558A3 Interspecific nicotiana hybrids and their progeny |
11/23/2000 | WO2000040759A3 Uses of flavivirus rna-dependent rna polymerases |
11/23/2000 | WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
11/23/2000 | WO2000038706A3 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
11/23/2000 | WO2000037685A9 Method of identifying a psychotropic agent using differential gene expression |
11/23/2000 | WO2000037608A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
11/23/2000 | WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof |
11/23/2000 | WO2000036910A9 Msh5 ablated mice and uses therefor |
11/23/2000 | WO2000036124A3 Plant cell cycle genes and uses thereof |
11/23/2000 | WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
11/23/2000 | WO2000034500A3 Methods for increasing the efficiency of gene transfer |
11/23/2000 | WO2000032782A3 Plant transcription factors |
11/23/2000 | WO2000032757A3 Plant vitamin e biosynthetic enzymes |
11/23/2000 | WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization |
11/23/2000 | WO2000031283A3 Regulatory sequences useful for gene expression in plant embryo tissue |
11/23/2000 | WO2000031262A3 Human neurotensin subtype 2 receptor |
11/23/2000 | WO2000031242A3 Engineered cytotoxic ribonuclease |
11/23/2000 | WO2000029420A3 Methods of making modified nucleosides |
11/23/2000 | WO2000028057A3 PLANT AMINOACYL-tRNA SYNTHETASES |
11/23/2000 | WO2000028031A3 Mitogenic regulators |
11/23/2000 | WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
11/23/2000 | WO2000028011A3 Fk506-based regulation of biological events |
11/23/2000 | WO2000027994A3 Chlamydia pneumoniae genome sequence |
11/23/2000 | WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd) |
11/23/2000 | WO2000026357A3 Transgenic and cloned mammals |
11/23/2000 | WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
11/23/2000 | WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
11/23/2000 | WO2000022144A3 Means and methods for modulating stomata characteristica in plants |
11/23/2000 | WO2000020450A3 Calcium channel alpha-2/delta gene |
11/23/2000 | WO2000018881A3 Intein mediated peptide ligation |
11/23/2000 | WO2000017369A3 Alzheimer's disease secretase |
11/23/2000 | WO2000016746A3 Immunogenic liposome compositions |
11/23/2000 | WO2000015790A3 Leptin induced genes |
11/23/2000 | WO2000015666A3 Compositions and methods for the treatment of tumors |
11/23/2000 | WO2000012740A3 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences |
11/23/2000 | WO2000009666A3 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
11/23/2000 | WO2000008157A3 Human anion transporter genes atnov |
11/23/2000 | WO2000007545A3 Apoptosis proteins |
11/23/2000 | WO1999057536A3 Cyclin activation kinase (cak) from human pathogens, and uses related thereto |